Suchergebnisse

1. Geurts B, Weishaar H, Mari Saez A, Cristea F, Rocha C, Aminu K, Tan MMJ, Salim Camara B, Barry L, Thea P, Boucsein J, Bahr T, Al-Awlaqi S, Pozo-Martin F, Boklage E, Delamou A, Jegede AS, Legido-Quigley H , El Bcheraoui C (2023): Communicating risk during early phases of COVID-19: Comparing governing structures for emergency risk communication across four contexts
   Front. Public Health 11: doi: 10.3389/fpubh.2023.1038989. mehr

2. Bartig S, Beese F, Wachtler B, Grabka MM, Mercuri E, Schmid L, Schmid-Küpke NK, Schranz M, Goßner L, Niehues W, Zinn S, Poethko-Müller C, Schaade L, Hövener C, Gößwald A, Hoebel J (2023): Socioeconomic Differences in SARS-CoV-2 Infection and Vaccination in Germany: A Seroepidemiological Study After One Year of COVID-19 Vaccination Campaign
   International Journal of Public Health 68: doi: 10.3389/ijph.2023.1606152. mehr

3. Bunse T, Koerber N, Wintersteller H, Schneider J, Graf A, Radonic A, Thuermer A, von Kleist M, Blum H, Spinner CD, Bauer T, Knolle PA, Protzer U, Schulte EC (2023): T-Cell-Dominated Immune Response Resolves Protracted SARS-CoV-2 Infection in the Absence of Neutralizing Antibodies in an Immunocompromised Individual.
   Microorganisms. 11 (6): 1562. doi: 10.3390/microorganisms11061562. mehr

4. Cohrdes C, Pryss R, Baumeister H, Eicher S, Knoll N, Hölling H (2023): Support- and meaning-focused coping as key factors for maintaining adult quality of life during the COVID-19 pandemic in Germany.
   Front. Public Health 11: doi: 10.3389/fpubh.2023.1196404. mehr

5. Mansour Ghanaie R, Boone I, Shamshiri AR, Karimi A, Amirali A, Marhamati N, Rostami MH, Pashaei N, Janbazi S, Azimi L, Khodaei H, Fallah F, Eckmanns T, Jansen A , Baradaran HR, Ourimi MM, Maham S, Elikaei A, Alebouyeh M (2023): Seroepidemiological and Molecular Survey for the Detection of SARS-CoV-2 Infection among Children in Iran, September 2020 to June 2021: 1-Year Cross-Sectional Study.
   Microorganisms. 11 (7): 1-12 doi: 10.3390/microorganisms11071672. mehr

6. Klamser PP, Andrea Vd, Lauro FD, Zachariae A, Bontorin S, Nardo Ad, Hall M, Maier BF, Ferretti L, Brockmann D, Domenico MD (2023): Enhancing global preparedness during an ongoing pandemic from partial and noisy data
   PNAS Nexus: doi: 10.1093/pnasnexus/pgad192. mehr

7. Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf M, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M (2023): Remdesivir for the treatment of COVID‐19
   Cochranelibrary: 123. doi: 10.1002/14651858.CD014962.pub2/full. mehr

8. Thom J, Walther L, Eicher S, Hölling H, Junker S, Peitz D, Wilhelm J, Mauz E (2023): Mental Health Surveillance am Robert Koch-Institut – Strategien zur Beobachtung der psychischen Gesundheit der Bevölkerung [Mental health surveillance at the Robert Koch Institute - strategies for monitoring the mental health of the population].
   Bundesgesundheitsbl: Published online: 27 February 2023. doi: 10.1007/s00103-023-03678-4. mehr

9. Marcus U, Schmidt D, Friebe M, Kollan C, Gunsenheimer-Bartmeyer B, Bremer V (2023): Gemeldete HIV-Erstdiagnosen 2021 – 2022.
   Epid Bull. (35): 3-18. doi: 10.25646/11678. mehr

10. Bernauer H, Schlör A, Maier J, Bannert N, Hanack K, Ivanusic D, (2023): tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2.
    Biol Methods Protoc. 2023 8 (1): doi: 10.1093/biomethods/bpad030. mehr

11. Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L (2023): Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
    Lancet Infect Dis.: S1473-3099(22)00801-5. doi: 10.1016/S1473-3099(22)00801-5. mehr

12. Akinnurun OM, Narvaez Encalada M, Orth J, Petzold M, Böttcher S, Diedrich S, Smitka M, Schröttner P (2023): Enterovirus A71-associated acute flaccid paralysis in a pediatric patient: a case report.
    J Med Case Rep 17 (1): 310. doi: 10.1186/s13256-023-04041-6. mehr

13. Biedermann P, Klink P, Nocke MK, Papp CP, Harms D, Kebelmann M, Thürmer A, Choi M, Altmann B, Todt D, Hofmann J, Bock CT (2023): Insertions and deletions in the hypervariable region of the hepatitis E virus genome in individuals with acute and chronic infection
    Liv Int 43: 794-804. doi: 10.1111/liv.15517. mehr

14. Wu E, Koch N, Bachmann F, Schulz M, Seelow E, Weber U, Waiser J, Halleck F, Faber M, Bock CT, Eckardt KU, Budde K, Hofmann J, Nickel P, Choi M (2023): Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients
    Pathogens 12 (6): 850. doi: 10.3390/pathogens12060850. mehr

15. Pilatz A, Arneth B, Kaiser R, Heger E, Pirkl M, Böttcher S, Fritzenwanker M, Renz H, Mankertz A, Schuppe HC, Wagenlehner F (2023): Acute orchitis deciphered: Coxsackievirus B strains are the main etiology and their presence in semen is associated with acute inflammation and risk of persistent oligozoospermia
    J Med Virol 95 (7): e28970. doi: 10.1002/jmv.28970. mehr

16. Klink P, Harms D, Altmann B, Dörffel Y, Morgera U, Zander S, Bock CT*, Hofmann J* (*contribute equally) (2023): Molecular characterisation of a rabbit Hepatitis E Virus strain detected in a chronically HEV-infected individual from Germany
    One Health 16: 100528. doi: 10.1016/j.onehlt.2023.100528. mehr

17. Cao LC, Martin V, Linh LTK, Giang TT, Chau NTM, Anh TNP, Nghia VX, The NT, My TN, Sy BT, Toan NL, Song LH, Bock CT*, Velavan TP* (*contribute equally) (2023): High Hepatitis E Virus (HEV) Seroprevalence and No Evidence of HEV Viraemia in Vietnamese Blood Donors
    Viruses 15 (10): 2075. doi: 10.3390/v15102075. mehr

18. Hörig M, Klaes SM, Krasovski-Nikiforovs S, van Loon W, Murajda L, Rodriguez RCO, Schade C, Spech A, Equihua Martinez G, Zimmermann R, Mockenhaupt FP, Seybold J, Lindner AK, Sarma N (2023): A COVID-19 isolation facility for people experiencing homelessness in Berlin, Germany: a retrospective patient record study
    Frontiers in Public Health 11: doi: 10.3389/fpubh.2023.1147558. mehr

19. Meyer ED, Dudareva S, Kollan C, Mauss S, Wedemeyer H, Schmidt D, Zimmermann R (2023): Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021
    Frontiers in Public Health 11: doi: 10.3389/fpubh.2023.1149694. mehr

20. Lehmann HC, Oberle D, Keller-Stanislawski B, Rieck T, Streit R (2023): Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021
    Eurosurveillance 28 (24): doi: 10.2807/1560-7917.ES.2023.28.24.2200744. mehr

Resultate 11.921 bis 11.940 von insgesamt 12.037